2024-02-01 2025-01-31 false No description of principal activity Capium Accounts Production 1.1 14605908 2024-02-01 2025-01-31 14605908 bus:AbridgedAccounts 2024-02-01 2025-01-31 14605908 bus:Micro-entities 2024-02-01 2025-01-31 14605908 bus:AuditExempt-NoAccountantsReport 2024-02-01 2025-01-31 14605908 bus:SmallCompaniesRegimeForAccounts 2024-02-01 2025-01-31 14605908 bus:PrivateLimitedCompanyLtd 2024-02-01 2025-01-31 14605908 2024-02-01 2025-01-31 14605908 2025-01-31 14605908 bus:RegisteredOffice 2024-02-01 2025-01-31 14605908 core:WithinOneYear 2025-01-31 14605908 core:AfterOneYear 2025-01-31 14605908 1 2024-02-01 2025-01-31 14605908 bus:Director1 2024-02-01 2025-01-31 14605908 bus:Director1 2025-01-31 14605908 bus:Director1 2023-01-20 2024-01-31 14605908 2023-01-20 14605908 bus:LeadAgentIfApplicable 2024-02-01 2025-01-31 14605908 2023-01-20 2024-01-31 14605908 2024-01-31 14605908 core:WithinOneYear 2024-01-31 14605908 core:AfterOneYear 2024-01-31 14605908 bus:EntityAccountantsOrAuditors 2023-01-20 2024-01-31 14605908 core:FurnitureFittings 2024-02-01 2025-01-31 14605908 core:FurnitureFittings 2025-01-31 14605908 core:FurnitureFittings 2024-01-31 14605908 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2025-01-31 14605908 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2024-01-31 14605908 core:CostValuation core:Non-currentFinancialInstruments 2025-01-31 14605908 core:CostValuation core:Non-currentFinancialInstruments 2024-01-31 14605908 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2025-01-31 14605908 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2025-01-31 14605908 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-01-31 14605908 core:Non-currentFinancialInstruments 2025-01-31 14605908 core:Non-currentFinancialInstruments 2024-01-31 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 14605908
England and Wales

 

 

 

AAYESHA PHARMA LTD



Abridged Accounts
 


Period of accounts

Start date: 01 February 2024

End date: 31 January 2025

AAYESHA PHARMA LTD
Contents Page
For the year ended 31 January 2025
  2025   2024
    £ £   £ £
Fixed assets   1,241      1,396 
Current assets 1,073      1,018   
Creditors: amount falling due within one year (2,930)     (817)  
Net current assets   (1,857)     201 
Total assets less current liabilities   (616)     1,597 
Net assets   (616)     1,597 
 

         
Capital and reserves   (616)     1,597 
 
NOTES TO THE ACCOUNTS

General Information
AAYESHA PHARMA LTD is a private company, limited by shares, registered in England and Wales, registration number 14605908, registration address 20 Empire Reach, High Street, Chatham, Kent, ME4 4EN.

The presentation currency is £ sterling.
1.

Accounting policies

Significant accounting policies
Statement of compliance
These financial statements have been prepared in compliance with FRS 105 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.
Basis of preparation
The financial statements have been prepared under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies.
The financial statements are prepared in sterling which is the functional currency of the company.
Turnover
Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts.
Tangible fixed assets
Tangible fixed assets, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis:
Fixtures and Fittings 10 Straight Line
2.

Tangible fixed assets

Cost or valuation Fixtures and Fittings   Total
  £   £
At 01 February 2024 1,551    1,551 
Additions -    - 
Disposals -    - 
At 31 January 2025 1,551    1,551 
Depreciation
At 01 February 2024 155    155 
Charge for year 155    155 
On disposals -    - 
At 31 January 2025 310    310 
Net book values
Closing balance as at 31 January 2025 1,241    1,241 
Opening balance as at 01 February 2024 1,396    1,396 


3.

Average number of employees

Average number of employees during the year was 1 (2024 : 1).


For the year ended 31 January 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's Responsibilities:
The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.

The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.

These accounts have been prepared in accordance with the micro-entity provisions and FRS 105, the Financial Reporting Standard applicable to the micro-entities regime. The accounts have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. The income statement has not been delivered to the Registrar of Companies.

The members have agreed to the preparation of abridged accounts.
The financial statements were approved by the director on 10 September 2025 and were signed by:


--------------------------------
Asiq Dastgir PATHAN MULANI
Director
1